Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Stephen B. Hanauer(University of Chicago Medical Center), Brian G. Feagan(Western University), Gary R. Lichtenstein(Hospital of the University of Pennsylvania), Lloyd Mayer(Mount Sinai Medical Center), Stefan Schreiber(Kiel University), Jean‐Frédéric Colombel(Hôpital Claude Huriez), Daniel Rachmilewitz(Tel Aviv Sourasky Medical Center), Douglas C. Wolf(Atlanta Gastroenterology Associates), Allan Olson, Weihang Bao, Paul Rutgeerts(Universitair Ziekenhuis Leuven)
Cited by 4,157
Abstract
Related Papers
No related papers found
Powered by citation graph analysis